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resumo 
 
 
O colagénio é uma proteína abundante em todos os animais, exercendo 
funções estruturais e reguladoras. Está presente em diversos locais e executa 
funções específicas, nomeadamente na manutenção dos tecidos e na 
conservação da sua estrutura celular, da sua força e integridade estrutural. 
Possui uma elevada importância na formação da matriz extracelular do tecido 
conjuntivo ao contribuir para as suas propriedades físicas.  
Colagenases são enzimas, mais especificamente metaloproteinases, com um 
característico domínio de ligação a zinco característico  
 Atualmente, as colagenases bacterianas possuem diversas aplicações 
industriais. Por exemplo, na clínica são utilizadas no tratamento de doenças 
associadas a acumulação excessiva de colagénio, como a Doença de 
Dupuytren, no desbridamento de queimaduras e feridas e também em terapia 
génica oncológica.  
O objetivo deste trabalho é a comparação e a otimização de dois métodos de 
purificação, para avaliar qual dos processos será mais rentável. Para tal, foi 
utilizado um método de purificação de proteínas recombinantes, que foram 
marcadas com histidinas, utilizando um método de cromatografia de afinidade 
com ião metálico imobilizado (IMAC). Para comparação, a purificação foi 
estabelecida utilizando um método em coluna, HisTrap FF e um método em 
batch.  
Os resultados obtidos através da quantificação de proteína, usando técnica de 
quantificação por densitometria demonstraram que a purificação quando 
realizada por coluna, apresenta maior rendimento. Através de ensaios 
realizados posteriormente foi possível demonstrar a atividade da ColAh por 
zimografia de gelatina, e quantificar a atividade colagenolitica contra o péptido 
sintético N-(3-[2-Furyl]acryloyl)-Leu-Gly-Pro-Ala (FALGPA). Os resultados 
também demonstram que a proteína recombinante apresentou estabilidade, 
quando armazenada ao longo do tempo, a diferentes temperaturas 
(temperatura ambiente; 4°C; -20°C). 
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abstract 
 
Collagen is an abundant protein in all animals and is the main component of 
numerous tissues, having also structural and regulatory roles. Collagen can be 
found in various numerous locations presenting specific functions, such as the 
establishment of the cellular shape, its strength and structural integrity, and is 
also involved in tissue maintenance. Moreover, collagen has an important role 
in the formation of the extracellular matrix of the connective tissue, by 
contributing to its physical properties. 
Collagenases are enzymes, more specifically metalloproteinases, with a zinc-
binding domain. These enzymes are able to digest the triple helical region of 
native collagen, cleaving its peptide bonds. In recent years, bacterial 
collagenases have been gaining interest for industry proposes, by offering a 
variety of applications. In the clinical area, collagenases are used as therapy for 
diseases associated with excessive deposition of collagen, as for example, in 
patients suffering from Dupuytren’s disease. The enzymes can also be used to 
help the debridement of wounds and burns, and also for cancer gene therapy 
applications.  
The objective of this work is the comparison and optimization of two methods of 
recombinant collagenase purification, evaluating which method provides the 
most cost-effective purification. For that purpose, a simple and high resolution 
method for purification of histidine-tagged recombinant protein was used. 
Immobilized metal ion affinity chromatography (IMAC) with a Ni Sepharose 6 
Fast Flow, through a column HisTrap FF 1ml or in batch were used. 
Results obtained through protein quantification by densitometry technique, 
showed that the purification using a column has higher yield. By zimography 
was possible determine the gelagenolytic activity of ColAh, and was also 
possible quantify the collagenolytic activity of ColAh, using a synthetic peptide 
N-(3-[2-Furyl]acryloyl)-Leu-Gly-Pro-Ala (FALGA). Obtained results also showed 
that the obtained recombinant protein is stable to storage over time and when 
submitted to different temperatures (room temperature; 4°C; -20°C). 
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1. INTRODUCTION 
1.1. COLLAGEN 
Collagen is a structural protein, abundant in all animals [1, 2], that exists in all shapes 
and sizes [3]. Approximately 30% of total proteins in mammalian bodies are various types 
of collagens, being essential to the structural components of connective tissues [4]. This 
protein is highly important in the formation of the extracellular matrix (ECM) of 
connective tissue and has diverse locations and specific functions [1, 5]. It is the major 
constituent of skin, tendons, blood vessels, and cartilage - being part of the organic 
component of bones, dentin, cornea and others structures of body, contributing for much of 
their physical properties [6-10]. As the major structural element of connective tissues, 
collagens are also found in the interstitial tissue contributing to stability of the tissues and 
organs and maintain their structural integrity [8]. Fibril-forming collagens, such as 
collagen type I and III, provide a major biomechanical platform for cell attachment and 
anchorage of macromolecules [4, 6, 9]. It is a long and rod-like molecule and is composed 
by three polypeptide chains (figure 1.1). Each chain contains 1050 amino acids wound 
around one another [7], and contains one or more regions characterized by the repeating 
amino acid motif Gly-Xaa-Yaa triplets, where Xaa and Yaa can be any amino acid, 
allowing to form a right-handed triple helical structure [3, 6, 7, 9-11].  
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Overview of triple helix of collagen. First high-resolution crystal structure of collagen. 
(Adaptated from Shoulders and Raines, 2009) 
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There are several types of collagens with the same function: help tissues withstand 
stretching. In the body, 80-90 % of collagen consists of collagen types I, II and III [7, 9]. 
These three types of collagen molecules pack together and form a long thin fibril with a 
similar structure [7].  
The different types of collagens are distinguished by the ability of their helical and non-
helical regions to associate into fibrils, to form sheets, or to cross-link different collagen 
types [7]. They are in general associated to particular tissues, and this heterogeneity may 
reflect the differential and specific physiological functions of each type [10]. 
The triplet Gly-Xaa-Yaa can occur in all types of collagen. This types can be 
categorized in fibrilar and non-fibrilar, however in case of nonfibrillar collagen, triple 
helical region it is disrupted at some locations within the triple-helical domain, resulting in 
a nonfibrillar architecture of the connective tissue core [2, 6, 9]. The most non-fibrillar 
collagen type is type IV and VI [2, 3]. Type IV collagen molecules are longer than the 
fibrillary collagen and it is the primary component of basement membranes, which 
represents another type of supramolecular organization which forms three dimensional 
networks [4, 6]. This membranes are specialized structures, present on the borders of 
tissues, underlying epithelial, endothelial, fat, muscle and nerve cells [3].  Classical 
fibrillary collagens account for 80-90% of all collagens in mammals and includes types I, 
II and III [7, 9]. Collagen type I is the most widely occurring collagen found in skin, 
tendon, bone, cornea, lung and the vasculature. Type II collagen, has a specific tissue 
distribution being limited essentially to cartilage, and type III is found in relatively elastic 
tissues such as embryonic skin, lung and blood vessels [3, 8].  
Fibrillar collagens are synthesized and secreted into the extracelular matrix as 
procollagen, with N- and C- terminal propeptide extentions (figure 1.2) [2]. The triple helix 
are the basic unit of fibrillary collagen. Have approximately 3000 Å in length and 15 Å in 
diameter [9]. As in all collagens, each fibrillar collagen molecule consists of three 
polypeptide chains, called α chains [3].  
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Figure 1.2. Fibrillar procollagens and fibril assembly. N- and C-terminal processing leads to 
spontaneous assembly of collagen fibrils, which are subsequently stabilized by the formation of covalent 
cross-link. (Adapted from Hulmes, 2008). 
 
 
 
 
 
 
 
 
 
 
Fibrillar collagens are synthesized in form of procollagens, with N- and C- terminal 
propeptide domains. Usually, C-propetides are removed through specific 
metalloproteinases. N-terminal extent processing depends the type of collagen [3].  
Interstitial collagen is assembled by three polypeptide strands [12]. If the residues in the 
position X and Y are Proline and Hydroxyproline the stability of triple helix increases. 
Thus, the amino acid sequence is related to the protein stability and their molecular 
interactions [9].  
1.2. COLLAGEN DEGRADATION 
Collagen is resistant to most common proteases due to its special structure and only can 
be degraded by a few types of proteases from mammals or bacteria [4]. During the past 
decades, the number of microorganisms capable to produce enzymes that degrade collagen 
have been increasing [7]. Degradation of collagen, occurs during various physiological and 
pathological conditions. However, only a limited number of proteases with unique 
characteristics can trigger collagen degradation [10, 13].  
1.2.1. Bacterial collagenases 
Over the years, substantiating evidence has been assembled to the hypothesis that 
growth and proliferation of pathogenic bacteria is dependent on the proteolytic enzymes 
action [5, 10]. Collagenases are endopeptidases that degrade native collagen in the triple 
helix region [11, 14]. They have a great ability to disaggregate connective tissues [15, 16] 
and have a characteristic multidomain MMP structure which is composed by a signal 
peptide, a propeptide, a catalytic domain, a hinge region, and a hemopexin domain [17].  
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Clostridial collagenases are large multi-modular zinc metalloproteases consisting of 
four to six domains and they belong to the MEROPS peptidase family M9, which 
comprises microbial metalloproteases with presumable collagenolytic activity [12, 18] . 
The first ones to be identified and characterized are the reference enzymes for comparison 
of newly discovered collagenolytic enzymes [9].  
The pioneer studies about clostridial collagenases’ characteristics were carried by 
Mandl, Seifter, Harper and their associates [19] and later by Van Wart and Bond [20] the 
classification work, and the first commercially available collagenase isolated from 
Clostridium histolyticum appeared in 1959 [14]. When the study of collagenases began, 
researchers have recognized the involvement of proteolytic enzymes from Clostridium in 
tissue putrefaction. Consequently, a Clostridium histolyticum extracellular enzyme, which 
was capable to digest tendons was isolated [10]. Thus, collagenases expressed by 
Clostridium histolyticum are preferred to others, since they are active practically on all 
mammalian collagen isoforms, even in their native conformation [15, 16]. These enzymes 
also completely degrade the obtained fragments into a mixture of small oligopeptides [12]. 
Based in kinetic and structural characteristics, clostridial collagenases can be classified into 
two classes: class I and II. This was established according its activities towards collagen, 
gelatin and synthetic substrates, freeze-thawing stability and the primary, secondary and 
tertiary structures [20, 21].  Collagenases from class I are highly active against collagen 
and moderately active against the synthetic peptide FALGPA used to kinetic studies of 
collagenases due to its characteristics of other proteinases are not capable of  hydrolyzing it 
[22]. Class II enzymes show moderate activity towards collagen but high activity against 
synthetic peptides [9].  
Collagenases can be further classified into two groups. The first are the ‘classic’ 
collagenases as the enzymes that cleave interstitial collagens, and the other group in ‘type-
specific’ collagenases, which is constituted by enzymes with capacity to degrade one or 
more specific collagens [23].  Collagenases are capable to degrade native triple helical 
collagen [12]. The enzymes demonstrate preference towards different fibrillar collagen 
subtracts cleaving only at well-defined site [12]. Under physiological conditions of pH and 
temperature, true collagenases cleave helical regions of collagen molecules in fibrillar form 
[4, 10, 16]. 
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The degradation of native triple helical collagen, for animal collagenases is crucially 
dependent to type of collagen and the species of origin. True collagenases, gelatinases or 
other bacterial proteases, are difficult to differentiate between them [9]. However, 
vertebrate gelatinases and collagenases are very easy to distinguish. First, vertebrate 
gelatinases do not hydrolase collagen fibers, only denatured collagen (gelatin). Vertebrate 
collagenases cut the collagen molecule at a single peptide bond, across the three α chains, 
forming specific 3/4 and 1/4 fragments. The fragments tend to uncoil into random 
polypeptides, being more susceptible to other proteases [9]. Therefore, vertebrate 
collagenases differ from bacterial collagenases in that they exhibit broader substrate 
specificity [14]. Bacterial collagenases can digest all collagen types, being capable to make 
multiple cleavages within triple helical regions, and degrade water-insoluble native 
collagens and water-soluble denatured ones [12, 14].  
1.3. APPLICATIONS OF COLLAGENASES 
Nowadays, important progresses have been made in the identification of new bacterial 
collagenases, and their mechanisms of collagen degradation [4].  
Microbial collagenases have several applications. These enzymes are used in diverse 
areas such as food industry [24], cosmetics, pharmaceutical and clinical areas [4] or in 
preparation of cells [9].  
1.3.1.Life science research 
A. Cell culture  
Cell culture has been widely used as an essential tool in diverse areas, as in molecular 
biology, toxicology and biotechnology, to address important scientific, technical and 
economic issues in biology [9].   
Enzymes are frequently used for tissue disaggregation in the first step of cell isolation 
and for cell dissociation during subculturing procedures to maintain in vitro cell cultures. 
Trypsinization is a procedure commonly used for dissociation and disaggregation of 
adherent cells from solid substrates during subculturing or in order to harvest cells to being 
extensively used in laboratory experiments to re-suspend cells adherent to the Petri dish 
wall during the process of harvesting cells [9, 25]. Trypsin, originally was isolated from 
pancreas, and has functions on the digestion of food and in the degradation of proteases 
inhibitors [26]. Furthemore, trypsin cleaves peptide bonds at the carboxyl side of lysine 
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and arginine residues, and its proteolytic activity may damage cells by cleaving the cell 
surface growth factor receptors or membrane proteins [9].  
The choice of the most suitable enzymes in the appropriate concentration, in order to 
obtain a maximum performance of functionally viable single cells, is crucial. Furthermore, 
fibrous tissues, with high collagen contents, are especially resistant to the action of trypsin 
digestion. In this case where trypsin would not be effective or may be damaging, 
collagenases are especially valuable [9].  
1.3.2. Food industry 
In food industry, the meat tenderness is one of the most concerning characteristics. 
Tenderness it is an important sensory quality in the meat. This can be influenced by 
various factors, as the length of the sarcomeres, the integrity of myofibrils that affect the 
actomyosin toughness and the connective tissues integrity which contribute to the 
background toughness [24].  
Over the years, different ways to improve physical and chemical methods for meat 
tenderization have been investigated. Proteolytic enzymes constitute one of the most 
progressive methods to increase meat tenderness. Nowadays, the enzymes as mesophilic 
and thermophilic proteases are used in meat tenderness [24]. 
Collagen constitutes 80% of the connective tissue and it is partly responsible by the 
toughness of red meats, being a significant factor influencing the texture of meat. 
Therefore, collagen digestion is an inducer of meat tenderness [9, 24]. Due to their 
characteristics, bacterial collagenases can be profitable in the process of meat tenderization 
[9].  
However, pathogenicity concernings have limited the industrial use of bacterial 
collagenases in the process of meat tenderization. To be an ideal meat tenderizer, the 
enzyme should be specific, with high activity at room temperature and easily inactivated 
during cooking [9, 24].  
In food industry, productions of recombinant collagenases in non-pathogenic strains 
would simplify their purification and avoid the presence of undesired virulence factors in 
collagenases.  
 
 
 9 
 
1.3.3. Health industry 
The health industry is probably the most relevant area for bacterial collagenases’ 
application, due to their ability matrix remodelling ability useful to treat several human 
diseases. These enzymes are successfully applied in the debridement treatment  of wounds 
and burns, cancer genetic therapy or electro-genetic therapy, treatment of lumbar disc 
herniation, to the treatment of chronic total occlusions, and Dupuytren's disease [4, 9] 
Collagenases from Clostridum hystoliticum are widely used in the clinical area, due to 
their ability to disaggregate connective tissues, to facilitate the isolation of cells of interest 
from multiple tissues, and used as a therapeutic drug for the removal of necrotic wound 
tissues for several decades [4]. These enzymes are preferred to others, because of their 
proteolytically active practically on all mammalian collagen isoforms, even in native 
conformation [15, 18]. Currently, clostridial collagenases were approved to be used for 
Peyronie’s disease as a non-surgical treatment [4].  
A. Wound debridement 
For more than half century, enzymatic debridement was suggested as a therapy and has 
been continuously applied till the current days [9, 27].   
Wound healing can be delayed if necrotic tissues are left in the wound site. Therefore, 
wound debridement is necessary to remove this necrotic tissue, cellular waste, and harmful 
exudate. Among various debridement methods, enzymatic wound debridement uses 
proteolytic enzymes to hydrolyze the denatured proteins (mostly collagens) in wound scar 
tissue [28].  
According to the study of Waycaster and Milne, which purpose was to determine the 
cost-effectiveness of enzymatic debridement using a collagenase ointment derived from C. 
histolyticum, but the cost of collagenase ointment is high [27]. 
Nonetheless, the use of a collagenase ointment, in a long-term care setting treatment of 
necrotic pressure can result in substantial cost savings compared to autolysis with a 
hydrogel dressing [27].  
1.3.4. Others applications  
Collagenases have a variety of applications as described above. In addition, 
collagenases have also applications in the leather industry [9].  
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In the leather industry there are two processes where the action of enzymes is useful. 
One is in the dyeing process, which is an important process in the leather industry that uses 
a large number of colorants. Other process is the unhairing process [9].  
Dyeing process uses synthetic colorants which are an important pollution source [9]. 
This process is an inevitable step of imprinting color to the leather, carried out in post-
tanning operations. Leather is a difficult substrate to dye due to the unique nature of the 
raw material that has variations within the matrix [29]. Employing collagenases in this 
process can be an advantage due to their application, aiming pollution reduction. After 
leather tanning, the use of collagenases results in opening-up of the fibrous leather network 
enhancing the diffusion of dyes into the leather matrix. This approach is more eco-friendly, 
uptaking up to 99% of the dye in leathers with improved bulk properties like softness, 
fullness, grain smoothness, feel and general appearance [9, 29].  
Unhairing is the first step in leather making, which consists in the removal of hair and 
epidermis from the pelt and the keratinous material that needs to fill the hair follicles. 
Since this process is highly pollutant, the use of enzymes has been studied, showing that 
they are capable to reduce the loaded pollution. Application of enzymes in the skin-
unhairing step accomplishes many weighty advantages, mainly on the final leather product 
quality and over comes all the environmental pollution by chemicals [30]. However, the 
costs of enzymes production, scale up and bioprocessing, suitability and efficacy of 
enzyme preparation to process different raw materials are concerning factors to implement 
enzymes in dehairing process [31]. 
 
1.4. RELEVANCE OF NOVEL COLLAGENASES 
Currently, bacterial collagenases are still largely unknown and understudied. However, 
the identification of novel collagenases is extremely important to a variety of applications 
in many fields, as the wide application in research, medicine, food processing and their 
enormous biotechnological potential [4, 5, 9].  
A large number of potential “true collagenases” is still unknown. With that, the 
characterization of novel bacterial collagenases will certainly expand the range of 
applications of these enzymes [9].  
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1.5. PURIFICATION OF RECOMBINANT PROTEINS 
Proteins have many potential applications in therapeutic, diagnosis and industry. A high 
throughput screening approaches are being performed in order to identify proteins with 
these potentials and applications [32, 33].  
In several areas as genomics, or proteomics, the number of experiments produced using 
recombinant techniques have been grown [32, 34]. Recombinant proteins’ production and 
purification are intimately related [34]. Nowadays, there are a large number of alternative 
methods for the same purpose. For example, the competition method is widely used to 
identify specific binding proteins among the proteins retained on an affinity resin [35].  
His-tag is the most commonly purification tag used worldwide and a variety of different 
techniques using this purification method have been developed [33]. Purification of 
recombinant proteins by affinity chromatography is one of the most efficient strategies due 
to the high recovery yields and purity achieved [32, 34, 36].  
Recombinant proteins can be manual purified or by using a chromatographic system, in 
order to save time and efforts [37].  
Chromatography techniques are used to purify proteins, having the purpose to separate 
the proteins according to the differences in specific properties. Affinity chromatography is 
designed to specifically recognize proteins, namely recombinant tagged proteins [37].  
Affinity tags are useful for purifying individual proteins and especially protein 
complexes, allowing diverse proteins to be purified in a single step [36, 37]. Usually, 
affinity purifications involve less chromatography steps resulting in a decrease of time to 
perform the methodology (figure 1.3). Affinity chromatography can have high yields, 
making this alternative economically favorable [32].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. General workflow of affinity purification of tagged recombinant proteins. (Adapted from 
recombinant protein purification principles and methods – GE Healthcare) 
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Developments in affinity chromatographic methods, such as Immobilized Metal Ion 
Affinity Chromatography (IMAC), are thus extremely important if the desired proteins are 
to be isolated in high yield and purity from complex biological feed stocks generated by 
fermentation or cell culture techniques [38]. IMAC is a simple and fast technique which 
has been successfully used for the purification of many recombinant proteins, produced by 
different microorganisms [39].  
Affinity tags can be defined as exogenous amino acid sequences with a high affinity for 
specific biological or chemical ligand [32]. Purification methods using affinity tags is an 
advantageous method due to its stability of the immobilized metal ions, high capacity of 
protein loading and reduced costs [40].  
These tags (namely the His-tag) usually have a high selective affinity towards a metal 
ion such as Ni2+ [37]. In general, Ni2+ is the preferred metal ion for purification of 
histidine-tagged proteins [30]. His-tagged proteins are enriched by interaction with the 
immobilized metal ions [40]. The tagged protein will be selectivelly bound to a metal ion 
charged media such as Ni Sepharose High Performance (HP) or Ni Sepharose 6 Fast Flow 
(FF) while others proteins will bind weakly. Generally, histidine-tagged proteins are the 
strongest binder among all the proteins in a crude sample extract.  
Currently, Escherichia coli is still the preferred organism for large-scale production of 
recombinant proteins. Fusion proteins have helped considerably in enhancing the solubility 
of heterologous proteins and their purification with affinity chromatography [41]. 
Histidine-tagged proteins expressed in E. coli can accumulate in two main forms: i) as 
inclusion bodies that are aggregates of denatured or partly denatured protein that lack 
biological activity but often allow high expression levels of the recombinant protein, or ii) 
as biologically functional soluble proteins[37].  
Figure 1.4 shows an overview of a common purification workflow for histidine-tagged 
protein, under native conditions.  
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As refered above, purification can be performed in many scales, having a number of 
columns with different sizes, and the columns can be prepacked with a chromatography 
medium or can be manually packed [37]. Ni Sepharose 6 Fast Flow is a bio process IMAC 
medium which contains 90 μm beads of highly cross-linked agarose, to which a chelating 
group has been coupled and after charged with Ni2+. Its properties of high flow makes it an 
excellent choice for scale-up and also its low Ni2+ leakage, high protein binding capacity, 
and its compatible with a wide range of additives used in protein purification [30].  
In summary, engineered purification tags can facilitate very efficient purification of 
recombinant proteins, resulting in high yields and purities in a few standard steps [33]. 
1 2 3 
Figure 1.4. Scheme of Affinity chromatography. 1) Equilibration: IMAC medium are equilibrated in 
binding buffer containing a low concentration of imidazole; 2) Samples application: sample applied 
under conditions favoring specific binding of tagged protein to the ligand, and unbound material are 
washed away 3) Elution: concentration of imidazole increase to promote elution of the tagged protein. 
(Adapted from recombinant protein purification principles and methods – GE Healthcare) 
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1.6. AIM OF STUDY 
In the present work, the main purpose was to  
i) Optimize a purification protocol for the recombinant collagenase ColAh 
a.  Comparedifferent purification methods  
ii) Characterize the recombinant protein – ColAh.  
 
In order to accomplish these objectives was also evaluated:  
- Gelatinolytic and collagenolytic activity; 
- ColAh application in the dissociation of cells in culture; 
- Perfomance of ColAh in collagen hydrolysis; 
- Storage stability at different temperatures of incubation. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
CHAPTER II 
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2. MATERIAL AND METHODS 
2.1. EXPRESSION OF RECOMBINANT COLAH 
For the expression of the recombinant collagenase (ColAh), 10 µl of a positive 
transformant (clone A stored in 15% glycerol, -80ºC) was used to inoculate a LA plate 
containing kanamycin (50 µg/ml) and grown overnight at 37ºC. Clone A was previously 
obtained by cloning in E. coli   and consists of an open reading frame that codes for a 
putative Aeromonas collagenase [42].  
Once clone A was grown, 15 ml of LB+50 µg/ml kanamycin were inoculated with a 
single bacterial colony from a fresh LB-agar plate and incubated at 37 °C with shaking 
(170-180 rpm) overnight. 50 µl of the overnight cultures were diluted 1:1.000 in fresh LB 
medium, containing the appropriate antibiotics, and incubated at 37 °C with shaking in 
250-ml baffled flasks until the bacterial cultures reached the planned optical density.  
One milliliter of the overnight culture was diluted in 50 ml LB+50 µg/ml kanamycin in 
a 250-ml blaffed flasks and incubated at 37ºC (170–180 rpm) until the bacterial cultures 
reached the planned optical density (OD600nm = 0.6).  
After induction with 0.5 mM IPTG, cultures were transferred to 26ºC (130rpm) and 
allowed to grow for additional 18 h.  
Cells were separated from the supernatant by centrifugation at 4ºC, for 10 minutes, at 
10.000 rpm. After centrifugation, the supernatant was collected and immediately processed 
for buffer exchange. 
2.2. PREPARATION OF THE CRUDE EXTRACT 
2.2.1. Addition of salts 
Buffers 
100mM Sodium Phosphate Buffer (SPB)1  
Table 2.1. Sodium Phosphate Buffer (100mM) 
Final Volume 500 ml 
NaH2PO4*H2O 1.55 g 
Na2HPO4 5.45 g 
The pH was adjusted to 7.4 and the final volume was brought to 500 mL with ultrapure water. 
 
                                                 
1 Sodium Phosphate Buffer: NaH2PO4*H2O; Na2HPO4 
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Crude extracts were supplemented with the appropriated volume of SPB stock solution 
(Table 2.1) containing salts (Table 2.2.), to the final concentrations: 20 mM SPB, 0.5 M 
NaCl and 5 mM imidazole. 
The mixture was homogenized by stirring for 30 minutes and the pH was adjusted to 
7.4. Afterwards, the samples were filtered using a 0.22 µm of cellulose acetate membrane 
syringe filter (sterile).  
 
Table 2.2. Example of contents for salts addition. Final volume of 625ml (500ml of supernatant – 125ml 
stock salt solution (100mM SPB)  
 
 
 
 
2.2.2. Dialysis  
Alternatively to salt addition, crude extracts (prepared, as described in section 2.2) were 
dialyzed in cellulose dialysis tubing with a molecular weight cut-off =14.000Da (Sigma-
Aldrich) against binding buffer 10 mM2. For efficient buffer exchange, dialysis was 
performed in a large stirred beaker overnight at 4°C with at least 2 buffer changes. 
2.3. PURIFICATION METHODS OF THE HISTIDINE-TAGGED 
RECOMBINANT COLAH 
2.3.1. Immobilized-metal affinity chromatography (IMAC) 
Buffers  
Stripping Buffer3 
Table 2.3. Stripping Buffer 
                                                 
2 Binding Buffer 10mM: 20mM sodium phosphate; 0.5M NaCl; 10mM  imidazole; pH 7.4. 
3 Stripping Buffer: 20 mM Sodium Phosphate, 0.5 M NaCl, 50 mM EDTA, pH 7.4 
Final Volume (Crude extract)  625 ml 
SPB 20mM 125 ml 
NaCl 0.5M 18.26 g 
Imidazole 5mM 0.43 g 
Final volume 500 ml 
Sodium phosphate (100mM) 100 ml 
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The pH was adjusted to 7.4 and the final volume was brought to 500 mL with ultrapure water. 
 
Elution Buffer I4 
Table 2.4. Elution Buffer I 
Final volume 500 ml 
Sodium phosphate (100mM) 100 ml 
NaCl  14.61 g 
Imidazole 17.02 g 
The pH was adjusted to 7.4 and the final volume was brought to 500 mL with ultrapure water. 
 
Elution Buffer II5 
Table 2.5. Elution Buffer II 
 
 
 
 
 
 
 
The pH was adjusted to 7.4 using and the final volume was brought to 500 mL with ultrapure water. 
 
 
 
                                                 
4 Elution Buffer I: 20mM sodium phosphate; 0.5M NaCl; 500mM imidazole; pH 7.4 
5 Elution Buffer II: 20mM sodium phosphate; 0.5M NaCl; 75mM imidazole; pH 7.4 
 
EDTA (500mM) 50 ml 
NaCl 14.61 g 
Final volume 500 ml 
Sodium phosphate (100mM) 100 ml 
NaCl  14.61g 
Imidazole 2.553g 
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Binding Buffer1  
 Table 2.6. Binding Buffer 
 
 
 
 
 
 
The pH was adjusted to 7.4 and the final volume was brought to 500 mL with ultrapure water. 
 
Purification was carried out in a pre-equilibrated (Binding buffer2, 1ml/min) HisTrap FF 
1ml column (GE Healthcare), in an AKTA FPLC system using the Unicorn 5.11 software. 
Crude extracts (20ml), pre-prepared in the appropriated salt conditions (prepared by 
dialysis or salt addition) were injected onto the resin. The target protein was eluted with 
75mM imidazole using a step gradient of imidazole (75, 100 and 500 mM imidazole) at a 
flow rate of 1 ml/min. A blank run was established before every purification procedure. All 
the water and buffer solutions were degassed [with Helium(g)] and filtrated (0.22 µm pore) 
before applied to the system. Collected fractions were stored at -20°C, until further 
characterization. 
A. Procedure of stripping and recharging the column of 1 ml.  
To improve protein purification, the column was stripped and recharged between every 
purification procedure, according to the manufacturer’s instructions.  
The prepacked column was washed with at least five column volumes with ultrapure 
water, buffer containing imidazole (10 mM imidazole), stripping buffer and at last with 
ultrapure water. In the second part of this step, the resin was recharged with NiSO4 0.1M, 
washed with ultrapure water and the column was equilibrated with binding buffer1.  
2.3.2. Batch/gravity-flow purification (BGP) 
A. Resin equilibrations and sample binding 
Batch purification was carried out with pre-equilibrated (binding buffer1) Ni Sepharose 
6 Fast Flow resin (GE Healthcare). Crude extract was loaded onto the resin with binding 
Final Volume 500 ml 
Sodium phosphate (100mM) 100 ml 
NaCl 14.61g 
Imidazole 0.341g 
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buffer. The resin was washed with buffer containing imidazole (Binding Buffer 10mM 
imidazole). The target protein was eluted with elution buffer II5 with 75 mM imidazole.  
B. Stripping and recharging with nickel sulfate  
After each purification, the resins were submitted to stripping and recharging with 
NiSO4. First the resins were washed at least twice 5-10 column volumes with stripping 
buffer2, then 5-10 column volumes of binding buffer1 and finally 5-10 column volume with 
ultrapure water (three - four times).  
The resins were recharged with NiSO4 0.1M and washed at least three times with 
ultrapure water.  
2.4. DESALTING (HIPREP 26/10 DESALTING COLUMN) 
Desalting procedure was performed according to the manufacturer’s instructions. 
Desalting was performed using a Sephadex G-25 Fine column (HiPrep 26/10 – GE 
Healthcare) coupled to an ÄKTA FPLC system. Before loading the sample, the system and 
column were washed with ultrapure water. The filtrated protein sample was loaded onto 
the column and the target protein was collected when the ABS (mAU) values started to 
increase. Sample collection was stopped when the conductivity reached 0.040 mS/cm. All 
the solutions (water and buffers) used in the HiPrep 26/10 desalting column were degassed 
[with Helium(g)] and filtrated (0.22 µm) before used onto the column. 
2.5. LYOPHILIZATION 
As final step, the samples were concentrated by lyophilization. This is a process where 
the water is removed from a product after it is frozen (-80°C) and placed under a vacuum, 
allowing the ice to change directly from solid to water vapor without passing through a 
liquid phase. The samples had approximately 15/20 ml each one. In this step a Snijders 
scientific type 2040 lyophilizer was used.  
2.6. PROTEIN QUANTIFICATION 
2.6.1.Colorimetric methods 
A. Pierce 660nm Protein Assay 
Pierce 660nm Protein Assay from Thermo Scientific was used to quantify the total 
protein concentration. This methodology is compatible with high concentrations of many 
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detergents, reducing agents and other commonly used reagents. Is a methodology based on 
the binding of a proprietary dye-metal complex to protein in acidic conditions. This causes 
a shift in the maximum absorption of the dye at 660nm, reproducing a colorometric 
response, dye-metal complex is reddish-brown and changes to green upon protein binding 
[43]. In this method bovine serum albumin (BSA) was used as standard.  
A standard curve was prepared with BSA final concentration from 25 μg/ml to 2000 
μg/ml and was measured with an absorbance at 660nm. The 25 µg/ml standard was 
prepared by mixing 10 μl of the 1000 μg/ml standard with 390 μg of 0.9% saline. 0.1ml of 
each replicate of standard, unknown sample and blank sample was added into an 
appropriately labeled test tube. Protein assay reagent (1.5ml) was added to each tube and 
vortexed to mix. The labeled test tubes were cover and incubated for 5 minutes at room 
temperature. Afterwards, total protein concentration was determined by measuring the 
absorbance at 660nm. 
B. BCA Protein Assay  
To determine the protein concentration of ColAh samples, the BCA Protein Assay 
Reagent Kit, from Thermo Scientific, was used. Bovine serum albumin (BSA) was used as 
a standard with a final concentration from 5 μg/ml to 250 μg/ml and was measured with an 
absorbance at 562nm, following the manufacturer’s instructions. 
This is a high-precision and detergent-compatible assay reagent, based on bicinchoninic 
acid (BCA) for the colorimetric detection of the total protein concentration compared to a 
protein standard. It consists in the reduction of Cu2+ into Cu1+ by proteins in an alkaline 
medium creating a biuret reaction. The amount of Cu2+ reduced is proportional to the 
protein concentration present in the samples. This method has a high working range (5-250 
µg/ml) [44].  
Total protein concentration of each sample was determined using a standard curve. The 
standards were prepared as described in the following table 2.7. The protocol was based on 
the manufacturer instructions. 
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Table 2.7. Diluted Albumin (BSA) Standards: (2mg/ml) used in the BCA protein assay. 
 Volume (μl) BSA volume (μl) 
Final concentration of BSA 
(μg/ml) 
A 700 100 μl of stock 250 
B 400 400 μl of A dilution 125 
C 450 300 μl of B dilution 50 
D 400 400 μl of C dilution 25 
E 400 100 μl of D dilution 5 
F 400 0 blank 
 
2.6.2. Spectrophotometry assay 
The NanoDrop spectrophotometer software (Thermo Scientific) uses the absorbance at 
280nm in combination with the molar extinction coefficient to calculate the protein 
concentration. The system was calibrated using 2 µl of ultrapure water, and loading 2 µl of 
sample gently homogenized, avoiding bubbles when mixing and pipetting. The 
concentration of the ColAh was calculated using the Beer-Lambert Law: 
 
 
 
 
 
 
 
 
The ColAh molar extinction coefficient () was estimated using ProtParam – ExPASy 
[45]. 
2.6.3. Densitometry analysis 
Densitometry analysis on SDS-PAGE (10% of acrylamide gel) was also used to 
quantify protein. The gel analysis was performed after staining the gel with Comassie 
Brilliant Blue R-250 and scanning on a GS-800 Calibrated Densitometer (Bio-Rad). To 
estimate the quantity of ColAh, the software Quantity One 5.11 (Bio-Rad) was used, using 
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known concentrations of BSA (1µg, 2 µg, 3 µg, 4 µg, 5 µg, and 10 µg) as standard which 
were loaded to the same SDS-PAGE gel. For each gel were performed replicates.  
2.7. EVALUATION OF PURITY AND ENZYMATIC ACTIVITY OF COLAH  
2.7.1. SDS-PAGE – Polyacrylamide gel electrophoresis  
This assay is adapted from the method described by Laemmli (1970). It is an 
electrophoretic separation of proteins in a polyacrylamide gel on the presence of SDS.  
In this methodology, the presence of ColAh was characterized on a 10% polyacrylamide 
gel. The samples were denaturated at 100°C for 5 minutes. Mini-Protean 3 Cell (Bio-Rad), 
linked to an electrical potential difference generator [PowerPac 300 (Bio-Rad)] were used. 
The gels were electrophorized for 100-120 minutes at 120Volts. After the run, the gel was 
emerged into a stain solution, Coomassie Brilliant Blue R-250 for 1 hour. The staining 
solution contains 0.25% (w/v) of staining, 10% of acetic acid (v/v) and 50% of ethanol 
(v/v). After, the gel was incubated into a destaining solution with 25% of ethanol (v/v) and 
5% of acetic acid (v/v), until the stains become visible.  Afterwards, the gel was scanned 
on a Gel Image Analyzer GS-800 Calibrated Densitometer (Bio-Rad) using the software 
Quantity One (Bio-Rad). For each assay, were tested three replicates for each sample. 
2.7.2. Zymography  
Zymography is an electrophoretic assay, which implies a co-polymerization of a 
substrate (gelatin) to the 10% polyacrylamide gel, allowing detection of enzymes and of 
their activity.  The samples were partially and reversibly desnaturated by SDS, but not 
reduced, and applied into a gel for separation. The run was performed at 4°C, 120 volts, for 
120 minutes. When the electrophoresis ends, the gel was washed with a non-ionic 
detergent, Triton X-100 (0.25%, v/v). Afterwards, the gel was incubated with a reaction 
buffer6 for 2 hours, at 37ºC, allowing the digestion of substrate by ColAh. The result was 
visualized after emerged the gel into a staining solution, Coomassie Brilliant Blue R-250. 
The gel was incubated in a staining solution with 0.25% (w/v) of staining, 10% of acetic 
acid (v/v) and 50% of ethanol (v/v), for 1 hour. Destaining step was performed by soaking 
the gel in 25% of ethanol (v/v) and 5% of acetic acid (v/v). The gel was incubated until 
digested areas become visible. For each assay, were tested three replicates for each sample. 
                                                 
6 Reaction Buffer: Tris 1.5M; NaCl 1M; CaCL2 1M; ZnCl2µM. 
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2.8. ENZYMATIC DETERMINATION OF COLLAGENASE ACTIVITY  
2.8.1. FALGPA assay  
Collagenase activity was determined according to Van Wart and Steinbrink (1981). This 
assay is used to determine the activity of collagenases and is based on the hydrolysis of 
synthetic peptide: 2-furanacryloyl-leu-gly-pro-ala (falgpa).  
For each assay, FALGPA reaction buffer7 and FALGPA were preincubated on a water 
bath at 37ºC, for approximately 20 minutes. Before each assay, a recommended test to the 
peptide was performed (negative control) [12, 22].  
FALGPA reaction buffer was used as a blank to calibrate the spectrophotometer. The 
assays mixtures were prepared by adding the FALGPA peptide to the FALGPA reaction 
buffer. The reaction was started by adding the adjusted volume of the enzyme sample 
(table 2.8). The continuous spectrophotometric rate determination (A345, Light path = 1 
cm) for each enzymatic assay was recorded for 10 minutes. Were performed three 
replicates for each sample.  
 
Table 2.8. Contents for activity assay using FALGPA. 
 
 
 
 
 
 
 
 
 
2.8.2. Collagen hydrolysis  
Collagen type I was prepared according to Duarte et al., 2005, and used as complex 
substrate for evaluating ColAh collagenolytic activity. ColAh was purified through a 
prepacked HisTrap FF 1 ml column, as previously described (section 2.3). NanoDrop 
                                                 
7 FALGPA buffer: 50 mM Tricine buffer; 10 mM CaCl2; 400 mM NaCl. Adjust to pH 7.5  
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spectrophotometer software (Thermo Scientific) was used to quantify the ColAh. 
Hydrolysis of collagen was carried out by incubating type I collagen (148 µg) with ColAh 
(2.5 µg) for 24h at temperature between 25-30ºC. After digestion, the samples were 
analyzed by SDS-PAGE polyacrylamide gel 6% of acrylamide, allowing to the detection 
of the hydrolysis of collagen by ColAh. The gel was running for 80 minutes at 100volts. 
Clostridial collagenase SERVA was used as positive control [46]. 
2.9. STORAGE STABILITY ASSAY  
To evaluate the storage stability of ColAh, it was incubated at diferent temperatures: 
room temperature, 4°C and -20°C, over time. At day 1 and 18 of storage, SDS-PAGE gels 
(7.5% of acrylamide) was performed, loaded with the samples (three replicates each) 
stored at differents temperatures.  The gels were running for 45minutes at 80Volts.  
The assay was performed accordingly the conditions stablished by the Patent NO.: US 
8,725,985 B2 – Clostridium histolyticum recombinant collagenase and method for the 
manufacture thereof [47].  
2.10. COLAH APPLICATION ON CELL CULTURE PROCEDURE 
C2C12 cell line derives from Mouse C3H muscle myoblasts. This cell line was used in 
order to evaluate the capacity of the recombinant collagenase (ColAh) for detachment of 
adherent cells. The maintenance of the cell line was carried out according to the protocol 
recommended by American Type Culture Collection (ATCC). Cells were grown in culture 
flasks at 37°C in a humidified atmosphere with 5% CO2 and maintained in Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 3.7g/l NaHCO3, 1% of antibiotic 
and 10% of Fetal Bovine Serum (FBS). Cell detachment was performed by using trypsin 
(control) or the ColAh in 0.1mg, 0.25mg, 0.5 mg and 1mg were added to each well. The 
culture plate was placed one minute at 37°C. To inhibit the action of trypsin and the 
ColAh, DMEM with 10% of FBS was added. Finally, cell culture morphology was 
evaluated by TC10 Automated Cell Counter, Bio-Rad Laboratories, Hercules, 
  
 
 
  
 
 
 
 
 
 
 
 
CHAPTER III 
 
 
 
 
 31 
 
Figure 3.1. Scheme of the process to obtain ColAh until purified  
3. RESULTS AND DISCUSSION 
In the present study, the main purpose was to evaluate the possible biotechnological 
potential of a recombinant protein – ColAh. For that, several assays were performed to 
evaluate different parameters, such as collagenolytic activity and purification yield.  
3.1. ACTIVITY AND STABILITY OF COLAH 
After ColAh expression and salt addition, different methodologies were implemented 
until reaching its pure (and still active) form. Immobilized metal affinity chromatography 
purification was carried out through batch procedure with an equilibrated Ni Sepharose 6 
Fast Flow resin (nominated batch gravidity protocol - BGP) (figure 3.1). 
 
 
 
 
 
 
 
 
 
 
 
 
One of the steps to evaluate and characterize the purified recombinant collagenase – 
ColAh, is to verify its activity. In this case, after purification by batch, ColAh was tested to 
assess its collagenolytic activity against a synthetic peptide.  
The assay requires the use of a spectrophotometer, able to automatically make readings 
over time, and with thermostated cell. To measure collagenolytic activity, the synthetic 
peptide 2-furanacryloyl-Leu-Gly-Pro-Ala (FALGPA) [22], that mimics the primary 
structure of the collagen molecule was selected and its hydrolysis was monitored over 
time., The Serva Collagenase NB 1 from Clostridium histolyticum was used as control 
[48]. The concentration of FALGPA degradation was determined spectrophotometrically 
and calculated using the Beer- Lambert Law. 
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Figure 3.2. Collagenolytic activity determination using the synthetic peptide FALGPA. a) Pure 
recombinant protein – ColAh - with salts addition and purification through batch. b) Commercial 
collagenase from Serva as control. 
 
Synthetic peptide FALGPA mimics the primary structure of the collagen molecule. It is 
considered a good substrate for collagenases [22], which hydrolyzes FALGPA results in a 
decrease in spectrophotometric absorvance at 324 nm [49].  
Figure 3.2 shows that ColAh is able to degrade the synthetic peptide, demonstrating that 
this recombinant protein retains collagenolytic activity. However, the collagenolityc 
activity of ColAh (1.16×10-04 mM/sec) is lower than the control (3.39×10-04 mM/sec), 
indicating that peptide degradation is lower than expected.  
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3.2. CELL CULTURE  
In this assay, the detachment abilities of ColAh were assayed using C2C12 cell line 
from Mouse C3H muscle myoblast.  Trypsin was used as control.   
 
Figure 3.3. C2C12 cells detachment by ColAh and trypsin. 
 
Trypsinization is a frequently used for the dissociation of adherent cells, in order to 
allow their harvest and use for a wide range of analysis [25]. Trypsin can be ineffective in 
when tissues are too fibrous or may cause damage in sensitive cells. The use of commercial 
collagenases for the cell detachment influences yield, viability and cells function. Viability 
and function of isolated cells are essential for several applications, as in diabetes therapy, 
pharmacological tests, scientific research and others [48].  
The purpose was to evaluate the cell release performance of ColAh from the culture 
plate and to compare its effects with trypsin’s performance.  
Figure 3.3 shows that, contrasting to trypsin, the recombinant protein was unable to 
completely dissociate C2C12 cells, even using higher concentrations of pure ColAh.  
Nevertheless, the results revealed slightly cell detachment by using 1mg of ColAh. This 
observation suggests that the ColAh added to the cells might not be at the required 
concentration to obtain a full detachment of the cells.  
One possible explanation is that the concentration used may not be sufficient to obtain 
the expected result. However, if higher doses of ColAh were used (higher than the 
commercial collagenases concentration required) the process would not be rentable. This 
may be due to the fact that the protein quantification (made using the BCA Protein Assay 
Reagent Kit) [44] was not the apropriate, estimating a larger protein concentration than the 
real purified amount of ColAh.  
Therefore, other methods for protein quantification were tested, such as the Pierce 660 
nm Protein Assay (Thermo Scientific) [43] and absorbance measurement at 280nm (using 
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a NanoDrop) [50]. However, again the protein quantification obtained from these methods 
was not in accordance with the corresponding analysis by SDS-PAGE (figure 3.4). The 
SDS-PAGE gel allows separating proteins according to their molecular weight [51], as 
well confirming the quantity of protein electrophoresed on the gel.  
The protein quantification methods used differ in several parameters. BCA Protein 
Assay is a method based in the reduction of Cu2+ to Cu1+ by proteins in an alkaline 
medium, the called biuret reaction. It is a highly sensitive and selective colorimetric 
detection of Cu1+ by bicinchoninic acid (BCA). The amount of Cu2+ reduced is 
proportional to the sample protein concentration. This method is highly sensitive to the 
presence of reducing agents [52].  
The Pierce 660 nm Protein Assay is also based in a colorimetric protein quantification. 
Bovine serum albumin was used as standard. This method is compatible with most 
detergents even in high concentration, reducing agents and other commonly reagents. 
However, it is known that certain substances interfere with the method [43]. This is the 
case of imidazole: the maximum compatible concentration is 200mM and EDTA 
(maximum compatibility concentration is 20mM) [43].  
The quantification by absorbance measurement (in a NanoDrop) allows to quantify 
purified proteins that contains Trp, Tyr residues or Cys-Cys disulphide bonds [50, 53].  
All the methods performed did not corroborate with the quantities added to the SDS-PAGE 
gels. This is well illustrated in figure 3.4, where the same protein quantity, determined by 
absorvance measurement (NanoDrop) is not confirmed by SDS-PAGE analysis.  
 
 
 
 
 
 
 
 
Figure 3.4. SDS-PAGE gel with two samples of purified ColAh from two different expressions. 1) Colah 
10µg - expression 19-05-15; 2) Colah 10µg - expression 22-04-15 
In figure 3.4, the SDS-PAGE gel shows the presence of ColAh, to relate the SDS-PAGE 
with protein quantification by NanoDrop. After protein quantification, 10 µg of ColAh 
2 1 MW 
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were load. As it is possible to observe, the amount loaded onto the gel did not match the 
quantification result.   
The results obtained until this stage of the work suggest that the ColAh maybe co-
purified with an interferent. From this point of view, the interferent might have also been 
quantified, giving erroneous values of ColAh concentration. This explains the divergent 
result obtained by SDS-PAGE analysis. 
Until here, the protein purification was carried by batch gravity purification (BGP). So, 
it is possible that the purification of ColAh by this method does not yield a pure enzyme at 
the end of the process. With that arises another hypothesis for the unexpected results, 
demonstrated in the first tasks. The method used for ColAh purification is not effective. In 
order to clarify this hypothesis collagenolytic activity of crude extract was assayed. 
3.3. ACTIVITY ASSAYS OF CRUDE EXTRACT 
In the previous tasks, it was demonstrated that the recombinant protein, in its pure form, 
did not exhibit the expected activity (figure 3.2), suggesting that during some phase of the 
protocol, expression or purification, the protein is losing activity. For that reason, a 
hypothesis that the purification process may not be carried as predictable was emerged. In 
this task, gelatinolytic and collagenolytic activity of crude extract was tested. 
Firstly, aiming to assess the deviation from the initial planning, a zymography assay 
was performed. This technique allows determining the apparent molecular weight and the 
gelatinolytic activity of a protein. Two samples of centrifuged crude extracts from two 
independent expression assays were loaded into a gelatin zymogram gel. In this way, it is 
possible to verify if the recombinant protein expression is being successful, and if not, this 
test allows the identification of the problem that was observed on the first presented 
results. 
Zymography is an electrophoretic assay with an appropriate substrate, in this case 
gelatin [13].  
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Figure 3.5. Zymography assay. 1- Centrifuged crude extract – Expression of day 17.04.15 
2- Centrifuge crude extract – Expression of day 20.04.15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.5 shows the two samples of crude extract from different expression and 
purification procedures. This result confirms that crude extract has gelatinolytic activity, 
shown in the zymogram as clear bands (substrate degradation) against dark background  
[13]. Thus, the expression step was being successful. This result, may suggest that the 
protein may be losing its activity in some part of the purification process. Collagenolytic 
activity of the crude extract was further assessed. As described above, the activity was 
measured using the synthetic peptide FALGPA; as control the commercial collagenase 
from Serva was used. This assay was performed using a spectrophotometer with readings 
over time, with a thermostated cell. 
T im e  ( s e c )
A
B
S
 (
3
4
5
n
m
)
0 2 0 0 4 0 0 6 0 0
0 .4 4 1
0 .4 5 1
0 .4 6 1
0 .4 7 1
a )
T im e  ( s e c )
A
B
S
 (
3
4
5
n
m
)
0 2 0 0 4 0 0 6 0 0
0 .1 5 7
0 .1 6 7
0 .1 7 7
0 .1 8 7
b )
 
Figure 3.6.  Collagenolytic activity determination using the synthetic peptide: FALGPA. a) Centrifuged 
crude extract of ColAh; b) Commercial collagenase Serva as control. 
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Figure 3.7. Different purification schemes used for ColAh  
Figure 3.6 shows that the crude extract has collagenolytic activity presenting a 
degradation velocity of 1.78×10-05mM/sec and the commercial collagenase shows a 
velocity of degradation of 2.18×10-05mM/sec. These results validate the results obtained by 
zymography (figure 3.5). Therefore, through the zymography gel (figure 3.5) and the 
determination of collagenolytic activity (figure 3.6.), it is confirmed that the crude extract 
has activity, leading to the conclusion that the absence of expected performance in 
protein’s purified form relies in the purification process. 
For that reason, the next task of this study was to analyze different purification methods 
to determine the most suitable method to purify the protein without having deleterious 
effect on its activity. 
3.4. COMPARISON BETWEEN DIFFERENT PURIFICATION METHODS 
As demonstrated in the previous subsections, the expression process was effective, but 
the purification process failed. 
The use of recombinant proteins has been increasing in recent years, highlighting their 
use in numerous applications [14]. Tagged recombinant protein are advantageous since 
they facilitate the purification while allowing its detection [15]. The purification of 
recombinant proteins can be performed using a chromatography system or manually. Ni 
Sepharose 6 Fast Flow is designed to scale up the purification of histidine-tagged proteins 
[15]. This method has a very high protein binding capacity, leading to lower costs per prep 
as a lower quantity of medium is required [16]. 
 
 
 
 
 
 
 
 
 
 
 
Crude extract 
Salts addition 
Purification – Column 
(IMAC) – A 
Purification – Batch (BGP) 
B 
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The purpose of the next task was to characterize the purification method according to 
the ColAh activity. Two methods were tested, to optimize the process (higher yields of 
pure ColAh). The ColAh was purified (figure 3.7.) by IMAC Sepharose 6 Fast Flow, using 
HisTrap FF 1ml prepacked column (A) and by batch purification with gravity flow (B), in 
order to choose the more profitable purification method.  
Protein yield in the different steps of each method of purification was determined by 
ColAh quantification using SDS-PAGE (10% of acrylamide). Known concentrations of 
BSA were loaded on gels to prepare a standard curve. 
 
Table 3.1. Values of the used volumes in the purification process and the obtained amount of protein. 
 
 
 
 
 
  
Table 3.2. Affinity purification by batch and column procedures: Elution volumes and ColAh yield. 
 
 
 
 
 
Table 3.1 and 3.2, shows the sample volume and protein quantity of each step. It is 
possible observe the course of ColAh during the different processes to obtain ColAh in its 
pure form.  
The following results present the SDS-PAGE made to quantify the ColAh. Image was 
acquired and analysed using a GS-800 densitometer (Bio-Rad) and Quantity One 1-D 
analysis software. This software allows quantifying, calculating and comparing the optical 
density of bands. 
 
 
 Volume Protein quantity 
Inoculum 400 ml 563.9 µg/ml 
Centrifuged 
crude extract 
315 ml 83.0 µg/ml 
Salts addition 390 ml 81.8 µg/ml 
 Batch (BGP) Column (IMAC) 
 Obtained 
volume 
Protein 
quantity  
Obtained 
volume  
Protein 
quantity 
Purification 350 ml 0.7 µg/ml 70 ml 9.6 µg/ml 
Desalting 500 ml  0.04 µg/ml 140 ml 0.6 µg/ml 
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In figure 3.8 it is possible observe the ColAh present on the gel. The loaded samples 
correspond to pure ColAh. ColAh sample obtained from the purification using column 
procedure (lane 7) and from batch purification procedure (lane 8).  
 Table 3.3. Values of the obtained quantity of total protein. 
 
 
 
 
 
Based on the densitometry method of quantification, the total protein concentration was 
calculated. The comparison between both methods, demonstrated that column 
chromatography is more effective purification process with a total protein quantity of 97.7 
µg, as it yielded more pure protein than purification by batch, which obtained 48.2 µg of 
total protein. 
After the quantity determination of total pure protein, ColAh activity was determined by 
zymography, besides assessing the differences between both purification methods, and its 
gellatinolytic activity.  
 
 
 
 Total protein quantity 
 Batch Column 
ColAh - 
lyophilized 
48.2 µg 97.7 µg 
100 
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50 
250 
150 
37 
25 
20 
kDa 
Figure 3.8. Example of an SDS-PAGE for protein quantification through densitometry, with known 
concentration of BSA as standard. 1) 1µg of BSA; 2) 2µg of BSA; 3) 3ug of BSA; 4) 4µg of BSA; 5) 5µg 
of BSA; 6) 10µg of BSA; 7) ColAh purified with column; 8) ColAh purified in Batch. 
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Figure 3.9. Zymogram (10%) of pure ColAh. 1) ColAh purified by column; 2) ColAh purified by batch. 
 
 
 
 
 
 
 
 
 
In figure 3.9, it is possible to observe that the recombinant collagenase retains activity 
and that the different methods of purification result in different yields of protein.  
The next step is to evaluate the collagenolytic activity of the ColAh, to assess the 
different effects on the collagenolytic capacity of this protein. 
3.4.1. Determination of collagenolytic activity 
The following procedure consisted in the quantification of collagenolytic activity, using 
a synthetic peptide FALGPA of pure ColAh obtained either by column or batch 
chromatography.  
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Figure 3.10. Collagenolytic activity determination of pure ColAh using the synthetic peptide: FALGPA. a) 
Recombinant protein purification by batch; b) Recombinant protein purification through column. 
 
Figure 3.10, shows a graph representing the two different purification methods. The 
concentration of FALGPA was determined spectrophotometrically using e324=2.250 mM-1 
cm-1. Graph a) represent the purification of ColAh by batch, presenting a collagenolytic 
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Figure 3.11. Scheme of two different purification processes tested. 
activity of 1.10×10-04 mM/sec. Collagenolityc activity of ColAh purified by column, 
represented in graph b) is 1.90×10-04 mM/sec. With the comparison between purification 
methods, the results show that the purification using the column procedure allows 
obtaining enzyme of higher activity than that obtained by batch purification method. 
3.5. COMPARISON BETWEEN DIALYSIS AND SALTS ADDITION IN 
PREPARATION OF CRUDE EXTRACT 
In order, to obtain ColAh in its pure form with higher activity, others parameters was 
tested. Preparation of crude extract was tested with dialysis and salts addition, as it is 
possible observe in the following representative scheme in figure 3.11. 
 
 
 
 
 
 
 
 
The following results represent the amount of total ColAh determined by densitometry 
quantification method, from the step with dialysis and salts addition. 
 
Table 3.4. Values of the used volumes in the purification process and the obtained amount of protein 
 
 
Results presented on table 3.4, demonstrate the course of ColAh and the differences 
between dialysis and salts additions to the crude extract. The amount of ColAh obtained 
from salts addition is higher than the mount obtained when it is performed dialysis. In sum, 
in the preparation of crude extract the yielded step is the salts addition. 
 Volume Protein quantity 
Inoculum 150.0 ml 630.5 µg/ml 
Centrifuged crude extract 135.0 ml 108.5 µg/ml 
Dialysis 67.5 ml 48.0 µg/ml 
Salts addition 84.5 ml 161.6 µg/ml 
Crude extract 
Dialysis Salts Addition 
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Figure 3.13. SDS-PAGE for protein quantification by densitometry, with known concentration of BSA 
as standard. a) & b): 1) 1µg of BSA; 2) 2µg of BSA; 3) 3ug of BSA; 4) 4µg of BSA; 5) 5µg of BSA; 6) 
10µg of BSA; a) 7) ColAh dialyzed and purified by through column; 8) ColAh dialyzed and  purified by 
batch purification; b) 7) ColAh with salts addition and purified through column; 8) ColAh with salts 
addition and  purified by batch purification. 
 
Figure 3.12. Scheme of crude extract preparation with Dialysis a) and Salts addition b), through two 
different methods of purification 
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However, ColAh samples were also tested from dialysis and salts addition steps in the 
different purification processes, as is demonstrated in the following scheme (figure 3.12).  
 
 
 
 
 
 
 
 
 
 Table 3.5. Total protein quantity – comparison between column and batch purification and salts addition 
versus dialysis in which purification method.  
 
 
 
 
 
 
 
 
 
 
 Total protein quantity 
  Dialysis Salts addition 
 Column Batch Column Batch 
ColAh - 
lyophilized 
2.6 µg 22.2 µg 54.1 µg 25.2 µg 
Dialysis 
Purification 
Column 
1) 
Purification 
Batch 
2) 
Salts addition 
Purification 
Column 
1) 
Purification 
Batch 
2) 
a) b) 
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After purification of samples from dialysis and salts addition steps, the protein quantity 
was quantified in order to understand the yield of each one. 
Based on the obtained results of protein quantification (table 3.5), using a densitometry 
approach (figure 3.13), it is possible to observe that the purification yield from dialyzed 
samples is higher for batch gravidity protocol. Besides, the samples were performed with 
salts additions present higher yield for purification using a column. 
However, from all tested samples, the ColAh which presented higher quantity was the 
sample performed with salts addition and purified through a column with 54.1 µg of ColAh 
in the end of the process. 
The following result shows a chromatogram from the purification using a column 
(figure 3.14). 
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Figure 3.14. Chromatogram of ColAh purification. Recombinant protein sample after salts addition. 
 
Figure 3.14 shown a chromatogram of purification performed using a column. The 
sample composition was adjusted to the composition and pH of the binding buffer by 
adding buffer (SPB), NaCl and imidazole. It is possible to observe a peak corresponding to 
ColAh with 137 mAU in a 15% gradient of eluent B (marked with an arrow).  
Afterwards, collagenolytic activity was assayed using a synthetic peptide FALGPA of 
pure ColAh prepared either with dialysis or salts addition, obtained by batch 
chromatography. 
 44 
 
 
T im e
A
B
S
 (
3
4
5
n
m
)
0 5 0 1 0 0
0 .2 9
0 .3 0
0 .3 1
0 .3 2
a )
T im e
A
B
S
 (
3
4
5
n
m
)
0 5 0 1 0 0
0 .4 1 5
0 .4 2 5
0 .4 3 5
0 .4 4 5
b )
 
Figure 3.15. Collagenolytic activity of ColAh determined by FALGPA hydrolysis. a) Recombinant protein 
purification with dialysis and purified in batch; b) Recombinant protein purification with salts addition 
purified in batch. 
 
Figure 3.15 shows the collagenolytic activity of recombinant ColAh after a) dialysis and 
after salts addition b). Both were purified using batch gravidity protocol (BGP).  
These results show that ColAh obtained from the procedure that includes the salts 
addition step presents a higher collagenolytic activity (1.01×10-04mM/sec) than that 
obtained using dialysis (5.73×10-05mM/sec).  Thus, the purification method using the 
addition of salts seems to be the most effective method for purifying ColAh. 
Batch and column purification of recombinant protein with salts addition were also 
compared.  
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Figure 3.16. Collagenolytic activity of ColAh determined by FALGPA hydrolysis. a) Recombinant protein 
purification with salts additions and purified in batch. b) Recombinant protein purification with salts 
addition purified in column. 
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Figure 3.16 shows the performance of ColAh purified by the two different methods. 
Purification using the column procedure presents higher collagenolytic activity (1.10×10-
04mM/sec) than that performed using batch protocol (5.13×10-05mM/sec).  
The comparison between column and batch purification reveals that the suitable method 
of purification is the column chromatography as it yielded higher amounts of purified 
protein, when salts are added. 
The preferred organism for large-scale production of recombinant proteins still is E. coli 
[54].  In a study performed by Karakus et al were they use E. coli to produce recombinant 
proteins, they also obtained a higher efficient of purification using affinity chromatography 
[55]. This technique has several adavantages because it is fast and reliable what makes it a 
suitable method for purification of histidine-tagged recombinant proteins[41].   
. 
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Figure 3.17. SDS-PAGE 6% Collagen type I hydrolysis. 1- Control I: Crude extract + ultrapure water; 2- 
Control II: Commercial collagenase: Serva + ultrapure water; 3- Control III: ColAh + ultrapure water; 4- 
Control IV: Collagen + ultrapure water; 5- Collagen + centrifuged crude extract; 6- Collagen + commercial 
collagenase: Serva; 7- Collagen + ColAh 
3.6. COLLAGEN HYDROLYSIS 
As described before, type I collagen is the major protein component of ECM. Thus, its 
hydrolysis is an important subject to address. Collagen degradation plays a key role in 
several clinical problems (e.g. in diseases where excessive deposition of collagen occurs – 
DD and PD) [18], in meat tenderization [19], leather prossessing [20], research and other 
many areas of application.  
The purpose of this assay was the evaluation of human type I collagen hydrolyses by 
ColAh. Human type I collagen was incubated at temperature between 25-30°C with the 
ColAh, for 24 hours. The reactions were stopped by adding the same volume of denaturing 
solution. The digestion reactions were analysed by SDS-PAGE (6% of acrylamide gel). In 
the SDS-PAGE gel four control samples were loaded, to evaluate all the components used 
in this assay. Collagen digestion was carried out according to Duarte et al. 2005. After 
running the electrophoresis, the gel was stained with Coomassie Brillant Blue R-250. 
  
  
  
 
  
 
 
 
 
 
The capacity to hydrolyze collagen is a mechanism of pathogenicity of diverse  
microorganisms that is very important [4]. Collagen molecules are composed of three 
helical chains. Each chain is characterized by the presence of two telopeptides, in both 
terminals.[18] 
In figure 3.17, the control IV (lane 4) which was incubated in the same conditions but 
without ColAh, shows intact human type I with its α chains (α1 and α2). The sample with 
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ColAh and human type I collagen (lane 7), shows the disappearance of human type I 
collagen α chains. The same result was obtained for collagen digestion by crude extract 
(lane 5), suggesting that ColAh in its pure form and crude extract, can hydrolyze collagen 
molecules. Commercial collagenase from SERVA, used as control, also hydrolyzed the 
human type I collagen as can be observed in the figure 3.17 (lane 6).  
Accordingly to Duarte et al., the hidrolysis of collagens by a proteinase under similar 
experimental conditions agree with the results obtained in this work [5]. 
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3.7. STORAGE STABILITY 
In this assay, storage stability of ColAh was tested, in order to evaluate the stability in 
function of storage temperature and time. Times of incubation and different temperatures 
were the selected parameters to accomplish the aim of this assay. ColAh was incubated for 
1 and 18 days at three different temperatures: room temperature, 4°C and -20°C. The 
samples were then analysed by SDS-PAGE using a 7.5% acrylamide gel. The samples 
were electrophoresed for 45 minutes at 80 volts (constant). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18. Samples of ColAh and commercial collagenase SERVA during differents storage periods. 
a) 1 and b) 18 days of storage. 1) Room temperature; 2) 4°C; 3) -20°C 
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Figure 3.18 shows the ColAh in the 1st (a) and 18th day (b) of storage, incubated at room 
temperature (lane 1), 4°C (lane 2) and at -20°C (lane 3). As it is possible observe, the 
ColAh at room temperature present low differences between 1st and 18th day and the 
samples at 4°C and at -20°C show no differences between the different periods of storage. 
Besides, the commercial collagenase SERVA shows more differences between day 1 and 
day 18 at room temperature. Thus, with this results is possible conclude that ColAh is 
stable for long periods of storage and at different temperatures.  
Study carried by Salome et al, tested the storage stability of different recombinant 
collagenases and the obtained results present low differences between the days of storage 
[16, 47].  
The present results and the literature suggest that recombinant enzymes present stability 
over days and at different temperatures of incubation. With that, it is possible to use the 
ColAh in highly reproducible protocols. 
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4. CONCLUSION AND FUTURE PERSPECTIVES 
This study allowed attaining several conclusions, concerning the appropriated method 
for purification of ColAh and its characterization. This characterization includes the 
gelatinolytic and collagenolytic activity of ColAh as well its stability and capacity to 
hydrolyze collagens. Also, the application of this recombinant collagenase in the 
dissociation of human cells in vitro was assessed. However, more studies should be 
performed to optimize the conditions to detachement of human cells.  
By different methods to purify ColAh, we can conclude that Ni Sepharose 6 Fast Flow 
column HisTrap FF 1ml represents the assays with the higher yield. Furthermore, the 
purified ColAh has a collagenolytic activity that equals the activity observed in the 
commercial collagenase, according with results obtained though FALGPA assay. Also, 
ColAh shows to be stable for long periods of time and even at different temperatures, what 
leads to the development of a wide range of possible applications, namely in the meat 
tenderization, in the treatment of diseases with excessive collagen deposition.  
In this way, this work provides a major evidence for the applicability of the recombinant 
collagenase, ColAh, as an alternative to the commercial enzymes.  
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